NOX-B11

N/A

Report date: 2024/11/22 10:28:58
NME

Base Information

Drug NameNOX-B11
Drug Alias NameNOX-B11
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionGhrelin modulators
TargetsGhrelin
Therapy Area/IndicationsPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharité – Universitätsmedizin Berlin
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharité – Universitätsmedizin Berlin
Active IndicationsN/A
Inactive IndicationsPrader-Willi Syndrome

Other Information

ATC CodeN/A
Related LinksN/A